corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 18438

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Knapp S
Linguistics Professor Examines Prescription Drug Websites
Dartmouth Now 2010 Jun 30
http://now.dartmouth.edu/2010/06/linguistics-professor-examines-prescription-drug-websites/


Full text:

Dartmouth Linguistics Professor Lewis Glinert and Jon Schommer, the associate head of the Department of Pharmaceutical Care and Health Systems at the University of Minnesota, have examined the corporate websites dedicated to the 100 best-selling prescription drugs. They found a startling lack of consistency in an industry where advertising standards are regulated by the Food and Drug Administration (FDA).
“Communicating via a website is common practice today,” says Glinert, “and consumers are very savvy about doing their own research on the Internet. The FDA has rules about direct-to-consumer print and television drug advertising, so we think it makes sense to also regulate websites and other marketing tools when it comes to prescription medicine. Consumers need consistent and balanced information.”
Glinert presented their study, “Manufacturers’ prescription drug web sites: A grey area of discourse and ethics,” at the Communication, Medicine and Ethics (COMET) 2010 Conference at Boston University School of Public Health on June 28. Glinert and Schommer have previously published on the topic of direct-to-consumer drug advertising and Glinert has also presented their research at an FDA hearing.
In this paper, Glinert and Schommer found that the websites:
Have no obvious linear narrative or ‘next page’ or conclusion; users move in a maze of text and navigation choices, some leading far away
Lack a popular genre name (such as infomercial), meaning that users come to them without a clear idea of how to perceive them
Have an unpredictable mix of information and promotion, content, verbal style, visuals, and layout
Often present safety and risk information in small font, in cumbersome un-bulleted blocks of text, detached from promotional text and videos, and below a page’s scrolling ‘fold’
Glinert notes that the Internet search engine Google has also been working to help consumers with their research on prescription drugs. A Google search of a prescription or generic drug name, for example Lipitor, will now display a summary and description at the top of the search results. The new feature, developed in partnership with the National Institutes of Health, links to NIH content and risk data.
“Our research provides justification for Google’s move,” says Glinert. “Only time will tell if this is a major change for the better.”

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Cases of wilful misrepresentation are a rarity in medical advertising. For every advertisement in which nonexistent doctors are called on to testify or deliberately irrelevant references are bunched up in [fine print], you will find a hundred or more whose greatest offenses are unquestioning enthusiasm and the skill to communicate it.

The best defence the physician can muster against this kind of advertising is a healthy skepticism and a willingness, not always apparent in the past, to do his homework. He must cultivate a flair for spotting the logical loophole, the invalid clinical trial, the unreliable or meaningless testimonial, the unneeded improvement and the unlikely claim. Above all, he must develop greater resistance to the lure of the fashionable and the new.
- Pierre R. Garai (advertising executive) 1963